A detailed history of Dimensional Fund Advisors LP transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 113,729 shares of TAK stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
113,729
Previous 114,254 0.46%
Holding current value
$1.54 Million
Previous $1.48 Million 9.34%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$13.0 - $15.08 $6,825 - $7,917
-525 Reduced 0.46%
113,729 $1.62 Million
Q2 2024

Aug 09, 2024

BUY
$12.6 - $13.67 $189,945 - $206,075
15,075 Added 15.2%
114,254 $1.48 Million
Q1 2024

May 10, 2024

BUY
$13.89 - $15.04 $99,605 - $107,851
7,171 Added 7.79%
99,179 $1.38 Million
Q4 2023

Feb 07, 2024

SELL
$13.36 - $15.43 $566,023 - $653,722
-42,367 Reduced 31.53%
92,008 $1.31 Million
Q3 2023

Nov 09, 2023

BUY
$15.03 - $16.32 $20,335 - $22,080
1,353 Added 1.02%
134,375 $2.08 Million
Q2 2023

Aug 09, 2023

SELL
$15.57 - $17.11 $157,148 - $172,691
-10,093 Reduced 7.05%
133,022 $2.09 Million
Q1 2023

May 12, 2023

BUY
$15.28 - $16.48 $9,412 - $10,151
616 Added 0.43%
143,115 $2.36 Million
Q4 2022

Feb 09, 2023

BUY
$12.42 - $15.62 $122,548 - $154,122
9,867 Added 7.44%
142,499 $2.22 Million
Q3 2022

Nov 10, 2022

BUY
$12.8 - $28.65 $137,126 - $306,927
10,713 Added 8.79%
132,632 $1.72 Million
Q2 2022

Aug 12, 2022

BUY
$13.12 - $15.03 $198,859 - $227,809
15,157 Added 14.2%
121,919 $1.71 Million
Q1 2022

May 13, 2022

SELL
$13.54 - $15.35 $144,701 - $164,045
-10,687 Reduced 9.1%
106,762 $1.53 Million
Q4 2021

Feb 09, 2022

BUY
$13.17 - $16.4 $420,386 - $523,487
31,920 Added 37.32%
117,449 $1.6 Million
Q2 2021

Aug 12, 2021

SELL
$16.55 - $18.64 $83,743 - $94,318
-5,060 Reduced 5.59%
85,529 $1.44 Million
Q4 2020

Feb 25, 2021

BUY
$15.39 - $18.97 $1.39 Million - $1.72 Million
90,589 New
90,589 $1.65 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.